Health Care Costs of Spontaneous Aneurysmal Subarachnoid Hemorrhage for Rehabilitation, Home Care, and In-Hospital Treatment for the First Year

被引:28
作者
Ridwan, Sami [1 ,4 ]
Urbach, Horst [2 ,5 ]
Greschus, Susanne [2 ]
von Hagen, Johanna [1 ]
Esche, Jonas [3 ]
Bostroem, Azize [1 ]
机构
[1] Univ Hosp Bonn, Dept Neurosurg, Bonn, Germany
[2] Univ Hosp Bonn, Dept Radiol, Bonn, Germany
[3] Univ Bonn, Dept Nutr & Food Sci, Bonn, Germany
[4] Evangel Krankenhaus Bielefeld, Dept Neurosurg, Bielefeld, Germany
[5] Univ Hosp Freiburg, Dept Neuroradiol, Freiburg, Germany
关键词
Costs; Economics; Expenses; Health care; Ischemic stroke; Subarachnoid hemorrhage; Treatment; LENGTH-OF-STAY; CEREBRAL ANEURYSMS; ISCHEMIC-STROKE; LIFETIME COST; RESOURCE USE; COILING; GERMANY; SCALE; DIAGNOSIS;
D O I
10.1016/j.wneu.2016.09.123
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND: Given the young age of onset and high probability of long-term disability after subarachnoid hemorrhage (SAH), the financial impact is expected to be substantial. Our primary objective was to highlight subsequent treatment costs after the acute in-hospital stay, including rehabilitation and home care, compared with costs for ischemic stroke. METHODS: The study included 101 patients (median age 52 years, 70 women) with aneurysmal SAH treated from July 2007 to April 2009. In-hospital costs were calculated using German diagnosis related groups. Rehabilitation costs depended on rehabilitation phase/grade and daily rate. Level of severity of care requirements determined the costs for home care. RESULTS: Of patients, 54% received coiling and 46% received clipping. The clipping group included more poor-grade patients than the coiling group (P = 0.039); 23 patients died. Of 78 surviving patients, 70 received rehabilitation treatment (68 in Germany). Mean rehabilitation costs were (sic)16,030 per patient. Patients in the clipping group generated higher rehabilitation costs and longer treatment periods in rehabilitation facilities (P = 0.001 for costs [(sic)20,290 vs. (sic)11,771] and P = 0.011 for duration (54.4 days vs. 40.5 days). Of surviving patients, 32% needed home care, of whom 52% required constant care. Multivariate regression analysis identified longer intensive care unit stay and poor Hunt and Hess grade as independent predictors of higher costs. CONCLUSIONS: Aneurysmal SAH prevalently affects working individuals with long-term occupational disability necessitating long-term medical rehabilitation for most patients and subsequent nursing care in one third of survivors. Overall, SAH treatment generates far higher costs than reported for ischemic stroke.
引用
收藏
页码:495 / 500
页数:6
相关论文
共 25 条
  • [21] First-Year Analysis of a New, Home-Based Palliative Care Program Offered Jointly by a Community Hospital and Local Visiting Nurse Service
    Pouliot, Katherine
    Weisse, Carol S.
    Pratt, David S.
    DiSorbo, Philip
    AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2017, 34 (02) : 166 - 172
  • [22] Independence, institutionalization, death and treatment costs 18 months after rehabilitation of older people in two different primary health care settings
    Inger Johansen
    Morten Lindbak
    Johan K Stanghelle
    Mette Brekke
    BMC Health Services Research, 12
  • [23] Independence, institutionalization, death and treatment costs 18 months after rehabilitation of older people in two different primary health care settings
    Johansen, Inger
    Lindbak, Morten
    Stanghelle, Johan K.
    Brekke, Mette
    BMC HEALTH SERVICES RESEARCH, 2012, 12 : 400
  • [24] One-year health and care costs after hip fracture for home-dwelling elderly patients in Norway: Results from the Trondheim Hip Fracture Trial
    Hektoen, Liv Faksvag
    Saltvedt, Ingvild
    Sletvold, Olav
    Helbostad, Jorunn L.
    Luras, Hilde
    Halsteinli, Vidar
    SCANDINAVIAN JOURNAL OF PUBLIC HEALTH, 2016, 44 (08) : 791 - 798
  • [25] Health care utilization and cost associated with switching biologics within the first year of biologic treatment initiation among patients with ankylosing spondylitis
    Yi, Esther
    Dai, Dong
    Piao, Olivia W.
    Zheng, Josh Z.
    Park, Yujin
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021, 27 (01) : 27 - 36